phorbolol myristate acetate has been researched along with bergamottin in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JH; Hwang, YP; Jeong, HG; Kang, KW; Yun, HJ | 1 |
1 other study(ies) available for phorbolol myristate acetate and bergamottin
| Article | Year |
|---|---|
Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by bergamottin via the inhibition of protein kinase Cdelta/p38 mitogen-activated protein kinase and JNK/nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression.
Topics: Antineoplastic Agents, Phytogenic; Carcinogens; Cell Line, Tumor; Cell Movement; Cytochrome P-450 Enzyme Inhibitors; Down-Regulation; Fibrosarcoma; Furocoumarins; Humans; I-kappa B Proteins; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; NF-kappa B; NF-KappaB Inhibitor alpha; Osmolar Concentration; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase C-delta; Protein Transport; RNA, Messenger; Signal Transduction; Tetradecanoylphorbol Acetate | 2010 |